As of Q3'25, BAC's ROS (Return on Sales) stands at 33.67%, reflecting a notable increase from the previous quarter's 29.05%. The latest data point marks the highest ROS observed since Q1'23, indicating a strong recovery. Over the period from Q1'23 to Q3'25, BAC's ROS exhibited significant volatility, with a sharp decline to 14.23% in Q4'23 followed by a gradual rebound. After reaching its lowest point in Q4'23, the metric steadily improved, maintaining levels above 28% throughout 2024 and into 2025, culminating in the recent peak. This trend suggests a period of operational challenges followed by consistent recovery and strengthening profitability.